Dr Autumn Lynn Hensley, MD | |
1400 Bryan Dr Ste 208, Durant, OK 74701-2157 | |
(580) 920-9063 | |
(833) 450-0357 |
Full Name | Dr Autumn Lynn Hensley |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 16 Years |
Location | 1400 Bryan Dr Ste 208, Durant, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316109630 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 29039 (Oklahoma) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Alliancehealth Durant | Durant, OK | Hospital |
Texoma Medical Center | Denison, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Durant Hma Physician Management Llc | 3375638976 | 20 |
Kinion E. Whittington, Do Apc | 3971554965 | 3 |
News Archive
The World Health Organization set a target for the influenza vaccination rate for 2006 of more than 50% of the elderly population and an increase to more than 75% by 2010. These rates have thus far not been achieved in the old German states. In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[48]: 845-50) the working group around Annicka M. Reuss presents rates from flu seasons past.
Echo Therapeutics, Inc., a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes.
If hospitals can perform more transradial, same-day percutaneous coronary intervention, or PCIs, not only will patients benefit because it is associated with have less complications, but collectively, hospitals across the U.S. could save $300 million each year, according to research published today in JACC: Cardiovascular Interventions.
OPKO Health, Inc. announced that it has made an investment in Fabrus, LLC, a privately held early stage biotechnology company with next generation therapeutic antibody drug discovery and development capabilities. In exchange for the Company's investment, the Company acquired approximately 13% of Fabrus' outstanding membership interests on a fully diluted basis.
Women with higher vitamin D levels in their blood following a breast cancer diagnosis had significantly better long-term outcomes, according to new research from Kaiser Permanente and Roswell Park Cancer Institute.
› Verified 7 days ago
Entity Name | Kinion E. Whittington, Do Apc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881776003 PECOS PAC ID: 3971554965 Enrollment ID: O20050423000093 |
News Archive
The World Health Organization set a target for the influenza vaccination rate for 2006 of more than 50% of the elderly population and an increase to more than 75% by 2010. These rates have thus far not been achieved in the old German states. In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[48]: 845-50) the working group around Annicka M. Reuss presents rates from flu seasons past.
Echo Therapeutics, Inc., a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes.
If hospitals can perform more transradial, same-day percutaneous coronary intervention, or PCIs, not only will patients benefit because it is associated with have less complications, but collectively, hospitals across the U.S. could save $300 million each year, according to research published today in JACC: Cardiovascular Interventions.
OPKO Health, Inc. announced that it has made an investment in Fabrus, LLC, a privately held early stage biotechnology company with next generation therapeutic antibody drug discovery and development capabilities. In exchange for the Company's investment, the Company acquired approximately 13% of Fabrus' outstanding membership interests on a fully diluted basis.
Women with higher vitamin D levels in their blood following a breast cancer diagnosis had significantly better long-term outcomes, according to new research from Kaiser Permanente and Roswell Park Cancer Institute.
› Verified 7 days ago
Entity Name | Durant Hma Physician Management Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043361116 PECOS PAC ID: 3375638976 Enrollment ID: O20070927000304 |
News Archive
The World Health Organization set a target for the influenza vaccination rate for 2006 of more than 50% of the elderly population and an increase to more than 75% by 2010. These rates have thus far not been achieved in the old German states. In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[48]: 845-50) the working group around Annicka M. Reuss presents rates from flu seasons past.
Echo Therapeutics, Inc., a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes.
If hospitals can perform more transradial, same-day percutaneous coronary intervention, or PCIs, not only will patients benefit because it is associated with have less complications, but collectively, hospitals across the U.S. could save $300 million each year, according to research published today in JACC: Cardiovascular Interventions.
OPKO Health, Inc. announced that it has made an investment in Fabrus, LLC, a privately held early stage biotechnology company with next generation therapeutic antibody drug discovery and development capabilities. In exchange for the Company's investment, the Company acquired approximately 13% of Fabrus' outstanding membership interests on a fully diluted basis.
Women with higher vitamin D levels in their blood following a breast cancer diagnosis had significantly better long-term outcomes, according to new research from Kaiser Permanente and Roswell Park Cancer Institute.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Autumn Lynn Hensley, MD 5879 N Washington Ave, Durant, OK 74701-7398 Ph: (580) 916-2730 | Dr Autumn Lynn Hensley, MD 1400 Bryan Dr Ste 208, Durant, OK 74701-2157 Ph: (580) 920-9063 |
News Archive
The World Health Organization set a target for the influenza vaccination rate for 2006 of more than 50% of the elderly population and an increase to more than 75% by 2010. These rates have thus far not been achieved in the old German states. In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[48]: 845-50) the working group around Annicka M. Reuss presents rates from flu seasons past.
Echo Therapeutics, Inc., a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes.
If hospitals can perform more transradial, same-day percutaneous coronary intervention, or PCIs, not only will patients benefit because it is associated with have less complications, but collectively, hospitals across the U.S. could save $300 million each year, according to research published today in JACC: Cardiovascular Interventions.
OPKO Health, Inc. announced that it has made an investment in Fabrus, LLC, a privately held early stage biotechnology company with next generation therapeutic antibody drug discovery and development capabilities. In exchange for the Company's investment, the Company acquired approximately 13% of Fabrus' outstanding membership interests on a fully diluted basis.
Women with higher vitamin D levels in their blood following a breast cancer diagnosis had significantly better long-term outcomes, according to new research from Kaiser Permanente and Roswell Park Cancer Institute.
› Verified 7 days ago
Allison A Taylor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr Ste 301, Durant, OK 74701 Phone: 809-209-0635 Fax: 316-634-0050 | |
Dr. Seetha Devi Sureddi, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr, Suite 300, Durant, OK 74702 Phone: 580-924-1700 Fax: 580-924-1736 | |
Braulio Manny Cuesta, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1400 Bryan Dr, Durant, OK 74701 Phone: 580-920-0105 Fax: 580-920-0893 |